Event: Asia-Pacific Pharma IP Leader Summit 2019

Dates: November 14 – 15, 2019

Venue: TBD, Beijing, China

Weblink: http://en.zenseegroup.com/p/301955/

Contact: Ann

Tel: +86 21 6565 0305

Email: marketing@zenseegroup.com

On March 19, 2019, the World Intellectual Property Organization (WIPO) published its global intellectual property report 2018.Asian innovators filed more than half of their international patent applications through WIPO for the first time in 2018, with significant growth in China, India and South Korea, the report noted. As a technology-intensive industry, pharmaceutical industry attaches great importance to patent application and intellectual property protection.

In recent years, the size of the global pharmaceutical market has maintained a steady growth, with China, South Korea, India and other emerging markets presenting a rapid growth momentum. Due to the different intellectual property policies of different countries, the strategic layout of global intellectual property, the differences of pharmaceutical intellectual property policies of Asia-pacific countries, the patent review process, litigation procedures and Generic drug patent strategy have gradually become the hot spots of the pharmaceutical intellectual property industry.

In this context, the 2019 Asia-pacific Pharmaceutical IP Leader Summit will be held in Beijing on November 14-15, and will attract more than 500 industry experts from domestic and foreign pharmaceutical companies, biotechnology companies, governments, associations, law firms, intellectual property agents and other companies to attend.

Agenda Framework:

Section 1：Interpretation of Policy: Development of Pharmaceutical IP under the New Legislative Landscape

Section 2：Pharmaceutical R&D Innovation and IP Protection -- Global Vision

Section 3：Case Sharing of Pharmaceutical Patent Invalidity, Infringement, Litigation

Section 4：Opportunities and challenges for generics companies under the new situation